Market Place
Sourcing Support
Biotechs behind J&J-bought Yellow Jersey partner on IBD drug
15 Nov 2024 //
FIERCE BIOTECH
Numab, Kaken Partner on ND081 for Inflammatory Bowel Disease
15 Nov 2024 //
GLOBENEWSWIRE
Numab Therapeutics Launches Phase 1 Trial of NM32 in Tumors
30 Oct 2024 //
GLOBENEWSWIRE
Johnson & Johnson Acquires Yellow Jersey Therapeutics For Atopic Dermatitis
11 Jul 2024 //
BUSINESSWIRE
J&J acquires experimental skin disorder drug for $1.25 billion
29 May 2024 //
BIOPHARMADIVE
J&J: Rights To Atopic Dermatitis Bispecific Antibody Candidate
28 May 2024 //
BUSINESSWIRE
Numab: J&J To Acquire Atopic Dermatitis Candidate NM26 From Yellow Jersey
28 May 2024 //
GLOBENEWSWIRE
Numab Therapeutics and Ono Pharmaceutical Announce an Option Agreement
14 Feb 2024 //
GLOBENEWSWIRE
Numab Therapeutics Announces First Patient Dosed in Phase 1 Study of NM26
19 Oct 2023 //
BUSINESSWIRE
Numab Therapeutics Announces First Subject Dosed in Ph1 Study of NM26 Program
15 May 2023 //
BUSINESSWIRE
Numab doses first subject in antibody therapeutic trial for AD
15 May 2023 //
CLINICAL TRIALS ARENA
Numab Therapeutics, Ono Pharmaceutical Enter Development and License Agreement
30 Mar 2022 //
BUSINESSWIRE
Numab, 3SBio’s Sunshine Guojian Expand Partnership to Develop NM28
14 Dec 2021 //
BUSINESSWIRE
Numab raises $111M to challenge Genmab, BioNTech for emerging PD-L1 opportunity
21 May 2021 //
FIERCEBIOTECH
Novo Holdings co-leads oversubscribed CHF 100 M Series C in Numab Therapeutics
20 May 2021 //
PRNEWSWIRE
Numab Therapeutics Completes Oversubscribed CHF 100 Million Series C Financing
20 May 2021 //
BUSINESSWIRE
Numab raises $111M to challenge Genmab, BioNTech for emerging PD-L1 opportunity
20 May 2021 //
FIERCEBIOTECH
Numab Therapeutics and Kaken Form Co-Development Alliance for a Next
13 Jan 2021 //
NUMAB
BI`s ties the knot with Numab on new antibodies;Cabaletta inks pact with Artisan
08 Jul 2020 //
ENDPTS
Numab & BI Enter into Collaboration to Develop Multi-specific Antibody
07 Jul 2020 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.